| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.10. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.10. | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| 05.10. | KeyBanc raises Lifestance Health stock price target on specialty care growth | 2 | Investing.com | ||
| 15.09. | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | 1 | Investing.com Deutsch | ||
| 11.09. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.09. | LifeStance prices 22.3 million share secondary offering at $12.35 | 2 | Investing.com | ||
| 09.09. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 4 | GlobeNewswire (USA) | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 09.09. | Canaccord raises Lifestance Health stock price target on growth outlook | 1 | Investing.com | ||
| 09.09. | LifeStance stockholders plan to sell 22.3 million shares | 1 | Investing.com | ||
| 10.08. | LifeStance Health gains as Hedgeye adds as new long idea | 1 | Seeking Alpha | ||
| 06.08. | LifeStance Q2 2026 slides: 94% EBITDA surge, raised outlook | 9 | Investing.com | ||
| 06.08. | LifeStance Q2 2026 slides: profitability surges as margins expand | 1 | Investing.com | ||
| 06.08. | LifeStance Health Group beats top-line and bottom-line estimates; raises FY26 outlook | 2 | Seeking Alpha | ||
| 06.08. | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | 989 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 07.07. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | Goldman Sachs initiates Lifestance Health stock at neutral | 1 | Investing.com | ||
| 04.06. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.05. | Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now | 5 | Zacks | ||
| 12.05. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.05. | LifeStance Health Group prices secondary offering at $8.15 per share | 1 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,795 | +1,69 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Für die Quartalszahlen des Medizinkonzerns am 4. November liege er beim... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,400 | -2,58 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,980 | +0,63 % | Weniger Blendung bei 64 Prozent der Testpersonen: Wie ZEISS Licht im Brillenglas steuert | ||
| TELADOC HEALTH | 7,558 | -0,55 % | Stifel hebt Kursziel für Teladoc Health an: Kostensenkungen stärken Margen | ||
| EUROFINS SCIENTIFIC | 87,22 | -0,27 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (Paris:ERF) (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 37,890 | +0,65 % | Ihre wichtigsten Termine: Apple, Ebay, Microsoft, Alphabet, Biogen und Boston Scientific legen Zahlen vor! | © Foto: Andrej Sokolow - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: US0162551016... ► Artikel lesen | |
| DEXCOM | 74,00 | +0,27 % | DexCom Inc. Q3 Sales Increase | WASHINGTON (dpa-AFX) - DexCom Inc. (DXCM) reported earnings for third quarter of $275.1 millionThe company's earnings came in at $275.1 million, or $0.72 per share. This compares with $283.8... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 137,65 | +2,53 % | Needham maintains Hold on Align Technology stock amid CEO change | ||
| INMODE | 12,165 | +2,79 % | InMode Ltd. - 6-K, Report of foreign issuer | ||
| PETMED EXPRESS | 1,057 | -1,31 % | PETMED EXPRESS INC: Was der CEO-Wechsel nun auslöst | ||
| TANDEM DIABETES | 17,700 | +0,57 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| INSULET | 137,05 | +1,07 % | Insulet Corp. Q2 Profit Advances | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released earnings for its second quarter that Increases, from the same period last yearThe company's earnings totaled $95.0 million, or $1.37 per... ► Artikel lesen | |
| MOLINA HEALTHCARE | 179,20 | +0,59 % | Bernstein reiterates Molina Healthcare stock rating on strong earnings | ||
| ORGANON | 12,340 | -0,40 % | Organon declares $0.02 quarterly dividend payable in December |